Literature DB >> 12727164

The role of ultrasound-guided cytology of groin lymph nodes in the management of squamous cell carcinoma of the vulva: 5-year experience in 44 patients.

T B Hall1, D P J Barton, P A Trott, N Nasiri, J H Shepherd, J M Thomas, E C Moskovic.   

Abstract

AIM: To assess the accuracy of ultrasound combined with fine-needle aspiration cytology (FNAC) in the detection of lymph node metastasis in patients with squamous cell carcinoma of the vulva.
MATERIALS AND METHODS: The groin nodes of 44 consecutive patients with primary squamous cell carcinoma of the vulva undergoing groin node dissection were assessed with ultrasound and FNAC. The results were compared with histology from subsequent inguinofemoral lymph node dissection. Twenty-nine patients underwent bilateral groin node dissections and 15 unilateral providing comparable data for 73 groins.
RESULTS: Histology demonstrated metastatic disease in 28 groins and no evidence of metastatic disease in 45. Ultrasound agreed with the histology in 67 of the 73 groins (92%), with two false-positives, four false-negatives and two indeterminate appearances. Cytology agreed with the histology in 65 of 72 FNAC samples obtained (90%), with six false-negatives, and one indeterminate result. No false-positive cytology results were seen. Ultrasound and FNAC together failed to detect metastatic disease in four groins, one with an indeterminate ultrasound appearance, another with indeterminate cytology, the two others each having a single positive inguinal node despite a negative ultrasound and FNAC.
CONCLUSION: The combination of ultrasound and FNAC provides a sensitive and specific tool for pre-operative assessment and may prevent unnecessary groin dissection and the attendant morbidity in selected patients with vulval cancer.

Entities:  

Mesh:

Year:  2003        PMID: 12727164     DOI: 10.1016/s0009-9260(02)00575-5

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  8 in total

Review 1.  Non-invasive and minimally invasive staging of regional lymph nodes in penile cancer.

Authors:  Ben Hughes; Joost Leijte; Majid Shabbir; Nick Watkin; Simon Horenblas
Journal:  World J Urol       Date:  2008-07-02       Impact factor: 4.226

2.  Computed tomography, magnetic resonance imaging and FDG positron emission tomography in the management of vulvar malignancies.

Authors:  Gigin Lin; Chao-Yu Chen; Feng-Yuan Liu; Lan-Yan Yang; Huei-Jean Huang; Yi-Ting Huang; Shih-Ming Jung; Hung-Hsueh Chou; Chyong-Huey Lai; Koon-Kwan Ng
Journal:  Eur Radiol       Date:  2014-12-06       Impact factor: 5.315

Review 3.  Vulvar Cancer: 2021 Revised FIGO Staging System and the Role of Imaging.

Authors:  Mayur Virarkar; Sai Swarupa Vulasala; Taher Daoud; Sanaz Javadi; Chandana Lall; Priya Bhosale
Journal:  Cancers (Basel)       Date:  2022-04-30       Impact factor: 6.575

4.  What next? Managing lymph nodes in men with penile cancer.

Authors:  Michael Leveridge; D Robert Siemens; Christopher Morash
Journal:  Can Urol Assoc J       Date:  2008-10       Impact factor: 1.862

5.  Imaging in primary penile cancer: current status and future directions.

Authors:  Rohit Kochhar; Ben Taylor; Vijay Sangar
Journal:  Eur Radiol       Date:  2009-08-06       Impact factor: 5.315

Review 6.  Imaging Features of Uncommon Gynecologic Cancers.

Authors:  Maura Miccò; Evis Sala; Yulia Lakhman; Hedvig Hricak; Hebert Alberto Vargas
Journal:  AJR Am J Roentgenol       Date:  2015-12       Impact factor: 3.959

Review 7.  The Role of Ultrasound in the Evaluation of Inguinal Lymph Nodes in Patients with Vulvar Cancer: A Systematic Review and Meta-Analysis.

Authors:  Debora Verri; Francesca Moro; Simona Maria Fragomeni; Drieda Zaçe; Sonia Bove; Federica Pozzati; Benedetta Gui; Giovanni Scambia; Antonia Carla Testa; Giorgia Garganese
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

8.  State of the art in vulvar cancer imaging.

Authors:  Maria Ana Serrado; Mariana Horta; Teresa Margarida Cunha
Journal:  Radiol Bras       Date:  2019 Sep-Oct
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.